# RETRACTED: Huang et al. Adenine Combined with Cisplatin Promotes Anticancer Activity Against Hepatocellular Cancer Cells Through AMPK-Mediated p53/p21 and p38 MAPK Cascades. Pharmaceuticals 2022, 15, 795

**Authors:** Jhen-Yu Huang, You-Cian Lin, Han-Min Chen, Jiun-Tsai Lin, Shao-Hsuan Kao

PMC · DOI: 10.3390/ph18020263 · Pharmaceuticals · 2025-02-17

## Full-text entities

- **Genes:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** Hepatocellular Cancer (MESH:D006528)
- **Chemicals:** Cisplatin (MESH:D002945), Adenine (MESH:D000225)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11831051/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11831051/full.md

---
Source: https://tomesphere.com/paper/PMC11831051